Evidence map›Paper›PMID 20956834›Full record

ReviewJournal of the National Cancer Institute. Monographs2010

Quality-of-life issues in patients with ductal carcinoma in situ.

Patricia A Ganz

Abstract readReview
In one paragraph

Review in Journal of the National Cancer Institute. Monographs, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Cancer overdiagnosis: a challenge in the era of screening.Journal of the National Cancer Center · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Article
  11. Article
  12. Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Patricia A GanzDivision of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Dr South, Rm A2-125 CHS, Los Angeles, CA 90095-6900, USA. pganz@ucla.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ductal carcinoma in situ (DCIS) as we know it today is a clinical entity that is primarily discovered through the finding of microscopic calcifications on a screening mammogram. Asymptomatic women who are found to have DCIS receive treatments that are similar to women with invasive breast cancer and experience substantial psychological distress in spite of having an excellent prognosis and normal life expectancy. More research is needed to determine the best way to communicate with women about this condition and to match the extent of treatment with the risk of serious future disease. Clinical and research efforts should focus on reducing the anxiety and psychological distress associated with the diagnosis of DCIS.

Indexed as

Quality of LifeAdultAgedAnxietyAttitude to HealthBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingChemotherapy, AdjuvantCombined Modality TherapyCost of IllnessDisease ProgressionFearFemaleHumansLife ExpectancyMastectomy

Identifiers

PMID20956834
PMCPMC5161073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.